Company / Operating Income
Biofrontera Inc. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$17.2M
FY2025
5-year range
-$25.2M / -$9.6M
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 5 years, ranging from -$25M in FY2022 to -$10M in FY2021.
Based on SEC 10-K filings.
-$17M in FY2025.
Improved from -$19M to -$17M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 24.1% year-over-year.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$17.2M | +24.1% |
| FY2024 | -$22.7M | -22.0% |
| FY2023 | -$18.6M | +26.3% |
| FY2022 | -$25.2M | -162.3% |
| FY2021 | -$9.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026